Steven Neier brings extensive experience in venture capital, strategic investment and early-stage company-building. He serves as Senior Director of Venture Investments on the Health team at Leaps by Bayer, where he leads search and evaluation as well as healthcare-focused investments. He previously helped launch and lead Binney Street Capital, the venture fund of the Dana-Farber Cancer Institute, where, as Principal, he sourced and oversaw investments in companies including Neomorph, Matchpoint Therapeutics, and Precede Biosciences. Before the fund’s launch, Dr. Neier helped execute Dana-Farber’s strategic alliance with MPM Capital, supporting translational research and new company formation.
During his postdoctoral fellowship at Dana-Farber, he led the strategic development of multiple platform technologies and co-founded NextRNA Therapeutics. Dr. Neier holds a B.S. in mathematics from Union College and a Ph.D. in immunology from the Mayo Clinic.
